Bovine coronavirus (BCoV) causes severe diarrhea in newborn calves, and is associated with winter dysentery in adult cattle and respiratory infections in calves and feedlot cattle. Although the Korean BCoV vaccine strain, BC94, was isolated in 1995, there has still been no report of a molecular characterization of the vaccine strain. To characterize the vaccine strain, relationships between BC94 and field strains were investigated, based on sequence analysis and cross-immunity. We determined the complete sequences of the HE, N, and S genes from BC94 and four NVRQS isolates (SUN5, A3, 0501, 0502). Due to its major role in antigenicity, the spike proteins of the BCoVs were analyzed. BC94 showed distinctive genetic divergence from field isolates collected from 2002 to 2005. BC94, SUN5, and A3 had no virulence-specific sequence and there was a single amino acid change, from asparagine to lysine at residue 175, in the polymorphic region. Strains 0501 and 0502 had virulence-specific sequences at all seven sites. Although the recently isolated Korean BCoVs and BC94 were genetically different, the cleavage site of spike genes at 763~768 (KRRSRR) and the antigenic domain II of the spike protein, amino acid position 528, were conserved in all NVRQS isolates. The antigenic relatedness of KCD9, representative of recent Korean BCoVs, was compared with the Korean vaccine strain BC94. KCD9 showed cross-reactivity against BC94 by virus neutralization (VN) test. These results suggest that BC94 is antigenically closely related to field isolates and is still effective as a vaccine strain.
INTRODUCTION

Bovine coronavirus (BCoV) is a member of the family
Coronaviridae of the order Nidovirales (1) and causes severe diarrhea in neonatal calves (CD), winter dysentery (WD) in adult cattle, and respiratory disease in feedlot cattle (2~6). BCoV is a 30-kb single-stranded, plus-sense RNA genome virus, consisting of five major structural proteins: nucleocapsid (N) protein, the transmembrane (M) protein, the small envelope (E) protein, the spike (S) protein, and the hemagglutinin-esterase (HE) protein (7) . Both S and HE glycoproteins are able to induce erythrocyte hemagglutination, by binding to the N-acetyl-9-Oacetylneuraminic acid (Neu 5,9Ac 2 )-containing receptor, but S protein has been proposed to play the major role to attachment of virus to cell surface receptor (8, 9) .
The coronavirus spike (S) protein, which is cleaved at amino acid positions 768 and 769, to form two subunits, S1
(N-terminus) and S2 (C-terminus), has several important functions, including viral attachment to the host cell, mediation of membrane fusion, and antibody neutralization 49 (10~17). Chouljenko reported that the spike gene includes a putative signal peptide (aa 1~17), S1A immunoreactive domain (aa 351~403), S1B immunoreactive domain (aa 517~621), hydrophobic region (aa 955~992), heptad repeat sequence (aa 993~1032), and carboxyl-terminal anchor sequence (aa 1312~1325) (18) .
The HE and S glycoproteins are more immunogenic than the N protein and M glycoprotein (19) . The S2 subunit is conserved, but a single amino acid change (528V) in the S1 subunit confers resistance to the viral neutralization (20, 21) .
Molecular analyses of American and Canadian isolates
have been conducted by comparing their S and HE genes (22) (23) (24) (25) (26) (27) . Korean calf diarrhea (KCD) strains and Korean winter dysentery (KWD) strains were isolated during the In the present study, we compared recently isolated Korean BCoV and the Korean vaccine strain, based on their immunological and genomic properties to determine whether the recently isolated strains should be considered as new vaccine strains. Cross-reactivity was observed between the Korean vaccine strain and presently widespread bovine coronaviruses. 
MATERIALS AND METHODS
Vaccine and field strains
S1R 5'-ACACCAGTAGATGGTGCTAT-3' S2F 5'-GGGTTACACCTCTCACTTCT-3' S gene 782~1550 S2R 5'-GCAGGACAAGTGCCTATACC-3' S3F 5'-CTGTCCGTGTAAATTGGATG-3' S gene 1459~2286 S3R 5'-TGTAGAGTAATCCACACGT-3' S4F 5'-TTCACGACAGCTGCAACCTA-3' S gene 2151~3022 S4R 5'-CCATGGTAACACCAATCCCA-3' S5F 5'-CCCTGTATTAGGTTGTTTAG-3' S gene 2691~3606 S5R 5'-ACCACTACCAGTGAACATCC-3' S6F 5'-GTGCAGAATGCTCCATATGGT-3' S gene 3439~4092 S6R 5'-TTAGTCGTCATGTGATGTTT-3' HE HEF 5'-GGATCCATGTTTTTGCTTCCT-3' HE gene 1~1275 HER 5'-CTCGAGTTATCGTAGTACGTCGGA-3' N NF 5'-GGATCCATGTTTTTGCTTCCT-3' N gene 1~1347 NR 5'-CTCGAGTTATATTTCTGAGTGTCTTCT-3'
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Trizol reagent (Gibco-BRL, Life Tech, Grand Island, NY, USA). Total cDNAs were synthesized from 2 μg of total RNA using Superscript II RNase H -reverse transcriptase (Gibco-BRL) with an oligo(dT) primer. Each cDNA was amplified by PCR using gene-specific primers (Table 1) , designed according to the published sequences of the S,
HE, and N genes of the Mebus strain (GenBank accession
No. U00735), described by Park et al (30) .
DNA sequence analysis and data analysis
RT-PCR products were purified using a Geneclean Turbo kit (Bio 101, Inc., La Jolla, CA, USA) according to the manufacturer's instructions. DNA sequencing was performed using an automated DNA sequencer (ABI PRISM 3730xl; Applied Biosystems Inc., Foster City, CA, USA).
Amino acid sequences were deduced using the DNAStar EditSeq software. Nucleotide and amino acid sequence alignments and phylogenic tree construction were performed using Clustal W in the DNAStar MegAlign software.
Virus neutralization (VN) test for cross-reactivity
Guinea pigs were inoculated with BcoV isolate KCD9 and BC94 to produce antisera. Serial two-fold dilutions of serum in α-MEM were mixed with the same volume (100 μl) of KCD9 and BC94 suspensions containing 200 TCID 50 /100 μl and incubated at 37℃ for 1 h. HRT-18 cell monolayers grown in 96-well microplates were washed three times with α-MEM and then inoculated with 100 μl of each virus-serum mixture. Serum samples were tested in triplicate wells. The cells were fixed with 80% acetone 5 days after inoculation and assessed by a direct immunofluorescence assay (32) . Virus-neutralizing antibody titers 
RESULTS
Molecular analysis of HE gene
The HE genes of BC94 (vaccine strain) and four NVRQS strains (SUN5, A3, 0501, and 0502) each contained an ORF of 1275 nucleotides encoding a predicted product 425 aa residues in length ( Table 2) . Pair-wise comparisons showed nucleotide and amino acid sequence identities between BCoV isolates ranging from 97.9% to 99.8% and from 98.1% to 100%, respectively. Sequence alignment was used to create a phylogenetic tree (Fig. 1) . Compared with BC94, we identified six amino acid substitutions in the HE genes of Korean field strains (0501, 0502, KCDs, 
Molecular analysis of S gene
The S genes of BC94 and four NVRQS strains each contained an ORF of 4092 nucleotides encoding a predicted product of 1346 aa residues. Sequence alignment analysis revealed nucleotide and amino acid sequence identities between BCV isolates ranging from 97.9% to 99.9% and from 97.9% to 100%, respectively. The phylogenetic relationships between S genes are shown in Figure 3 . In total, 21 aa changes were detected in the S1 subunit (aa 1~768). Fifteen amino acid changes were detected in polymorphic regions in the N-terminal region of the S1 subunit (aa 1~ 330) (Fig. 4) . The amino acid sequences of SUN5 and A3 strains were 100% identical to those of the BC94 strain. In the cases of 0501 and 0502, amino acids at positions 499, 501, 510, 543, and 578 were identical, but those at A33V, I40T, R88T, I100T, K115D, L147F, N149S ,   H169N, H173N, K175N, R179Q, L248M, S252N , M256L, V465A, and H478D were changed, compared with BC94.
The amino acid sequences of 0501 and 0502 were similar to those of recent Korean isolates, KCDs and KWDs. To understand the immunoserological relationships between BC94 and field strains, a cross-reactivity assay was performed. KCD9 was chosen because it is a representative strain with the most common sequence among the field isolates, based on the results of sequence analysis.
The VN antibody titers of KCD9-inoculated antisera against homologous KCD9 and heterologous BC94 were not significantly different. These results indicated that BC94 is antigenically closely related to KCD9 and is still considered as an effective vaccine strain. Further studies are required to investigate cross-protection in calves.
